top of page

Search

COVID guidelines update and Antifungal prophylaxis guidelines

francoisbourdeau
Oct 6, 2022
1 min read

The MUHC ASP committee is happy to announce the update and publication of several guidelines:

Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg
COVID management guidelines (minor changes)
COVID outpatient decision tree : inclusion of situation in which to give Evusheld
Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)

We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.

Good reading to all and happy thanksgiving!

Francois Bourdeau, ASP co-chair

Recent Posts

New guide : IV to PO

The ASP committee is happy to make available the new guide IV to PO! It covers situation in which a switch to PO is indicated for certain...

We have a new look!

The MUHC ASP website has gone through a re-do: combination of spring cleaning and cosmetic changes, but keeping all the content! check...

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

Commentaires

bottom of page